Table of Contents

company-logo

Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular degeneration, and diabetic retinopathy. It also develops UBX1967 for the treatment of ophthalmologic diseases; UBX2050, a human anti-Tie2 agonist monoclonal antibody for the treatment of age-related eye diseases; and UBX2089, a a-Klotho hormone drug candidate for multiple neurology indications. The company was formerly known as Forge, Inc. and changed its name to Unity Biotechnology, Inc. in January 2015. Unity Biotechnology, Inc. was incorporated in 2009 and is headquartered in South San Francisco, California.

Unity Biotechnology Dividend Announcement

• Unity Biotechnology does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Unity Biotechnology dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Unity Biotechnology Dividend History

Unity Biotechnology Dividend Yield

Unity Biotechnology current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Unity Biotechnology stock? Use our calculator to estimate your expected dividend yield:

Unity Biotechnology Financial Ratios

P/E ratio-0.96
PEG ratio-0.04
P/B ratio1.49
ROE-101.47%
Payout ratio0.00%
Current ratio3.45
Quick ratio3.45
Cash Ratio1.01

Unity Biotechnology Dividend FAQ

Does Unity Biotechnology stock pay dividends?
Unity Biotechnology does not currently pay dividends to its shareholders.
Has Unity Biotechnology ever paid a dividend?
No, Unity Biotechnology has no a history of paying dividends to its shareholders. Unity Biotechnology is not known for its dividend payments.
Why doesn't Unity Biotechnology pay dividends?
There are several potential reasons why Unity Biotechnology would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Unity Biotechnology ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Unity Biotechnology has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Unity Biotechnology a dividend aristocrat?
Unity Biotechnology is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Unity Biotechnology a dividend king?
Unity Biotechnology is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Unity Biotechnology a dividend stock?
No, Unity Biotechnology is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Unity Biotechnology stocks?
To buy Unity Biotechnology you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Unity Biotechnology stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.